Role of progestogens in MHT (RU)

5 years ago

Luciano Pompei,

Tommaso Simoncini

You may also like

Impact of estrogen deficiency on quality of life in Asia and the role of continuous combined MHT in treatment (RU)

Impact of estrogen deficiency on quality of life in Asia and the role of continuous combined MHT in treatment (RU)

2 years ago

How to handle the daily practice challenges when prescribing oral MHT (RU)

How to handle the daily practice challenges when prescribing oral MHT (RU)

2 years ago

Khulood Al Awadi,

Naoual Merrouche

Benefits of oral combined MHT for estrogen deficiency symptoms treatment (RU)

Benefits of oral combined MHT for estrogen deficiency symptoms treatment (RU)

2 years ago

Angelica Hirschberg,

José Vázquez,

Patricio Barriga

Personalized oral combined MHT and long-term effects: How to choose according to the patient’s needs (RU)

Personalized oral combined MHT and long-term effects: How to choose according to the patient’s needs (RU)

2 years ago

Larysa Mishchenko,

Suvarna Khadilkar,

Practical Aspects of MHT: Regimen, dosage, duration of treatment, and adverse events handling (RU)

Practical Aspects of MHT: Regimen, dosage, duration of treatment, and adverse events handling (RU)

3 years ago

Dimitrios Goulis,

Tobie de Villiers

Menopause beyond hot flushes: How to address common symptoms in the Asian population? (RU)

Menopause beyond hot flushes: How to address common symptoms in the Asian population? (RU)

3 years ago

The long-term effects of oral combined estrogen + progestogen: Which patient profile benefits the most? (RU)

3 years ago

José Vázquez,

Paulina Villaseca

EMAS Roundtable: Hot issues on menopause (RU)

EMAS Roundtable: Hot issues on menopause (RU)

3 years ago

Antonina Smetnik,

Dimitrios Goulis,

EMAS Roundtable,

Rebecca Thurston

Ultra-low dose menopausal hormone therapy (RU)

Ultra-low dose menopausal hormone therapy (RU)

3 years ago

Angelica Hirschberg,

Oleksandra Gromova

Menopause hormone treatment beyond vasomotor symptoms (RU)

Menopause hormone treatment beyond vasomotor symptoms (RU)

4 years ago

Antonina Smetnik,

Dimitrios Goulis,

José Vázquez,

Pablo Gutierrez